An examination of recently revised differentiated thyroid cancer guidelines

Current Opinion in Oncology

Volumn 23, Issue 1, 2011, Pages 1-6

  Miller, Barbra S ^a   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer; Endocrine; Guidelines; Papillary; Thyroid

Indexed keywords

LEVOTHYROXINE; LITHIUM; RADIOACTIVE IODINE; THYROTROPIN;

ARTICLE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; DIFFERENTIATED THYROID CANCER; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; OVERALL SURVIVAL; PAPILLARY THYROID CANCER; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT CANCER; RECURRENT LARYNGEAL NERVE PALSY; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME;

CELL DIFFERENTIATION; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; THYROID NEOPLASMS;

EID: 79851510862     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833fc9c4     Document Type: Article

References (25)

1. Cooper DS, Doherty GM, Haugen BR, and the American Thyroid Association Guidelines Taskforce on Thyroid Nodules. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167-1214.
2. Kloos RT, Sherman SI, Tuttle RM; the NCCN Thyroid Carcinoma Panel Members. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma V.1.2010. www.nccn.org. [Accessed 25 July 2010].
3. Pitoia F, Ward L, Wohlik N, et al. Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metab 2009; 53:884-897.
4. British Thyroid Association, Royal College of Physicians. Guidelines for the Management of Thyroid Cancer. 2nd ed. In: Perros P, editor. Report of the Thyroid Cancer Guidelines Update Group. London: Royal College of Physicians; 2007.
5. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer. Am (Pubitemid 26361908)
6. Cooper DS, Doherty GM, Haugen BR, and the American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-142.
7. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007; 142:906-913; discussion 913.e1-2. Epub 2007 Nov 5. Erratum in: Surgery. 2008,143:302. (Pubitemid 350184098)
8. Kloos RT, Sherman SI, Tuttle RM; the NCCN Thyroid Carcinoma Panel Members. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Thyroid Carcinoma V.1.2009. www.nccn.org. [Accessed 8 May 2010].
9. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 2008; 5:1 -17; This article is available from: http://www. cytojournal.com/content/5/1/6.
10. Pacini F, Schlumberger M, Dralle H, and the European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154:787-803. (Pubitemid 43997716)
11. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2008; 31:895-904.
12. Mazzaferri EL. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology 2009; 23:579.
13. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 2009; 19:683-689.
14. Doherty GM. Prophylactic central lymph node dissection: continued controversy. Oncology 2009; 23:603.
15. Tuttle RM, Fagin JA. Can risk-adapted recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients? Oncology 2009; 23:592.
16. Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228:320-330. (Pubitemid 30191695)
17. Stavrakis AI, Ituarte PH, Ko CY, et al.Surgeon volumeasapredictorofoutcomes in inpatient and outpatient endocrine surgery. Surgery 1997; 142:887-899.
18. Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009; 19:1153-1158.
19. Biondi BS, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010; 20:135-146.
20. Gharib H, Papini E, Pashcke R. Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol 2008; 159:493-505.
21. Vidal-Trecan GM, PazartLH, Massol JA. A method for guideline development: assessing practical feasibility and adaptation of thyroid nodule guidelines. J Eval Clin Pract 1999; 5:189-198. (Pubitemid 29288584)
22. Hundahl SA, Cady B, Cunningham MP, et al.,US and German Thyroid Cancer Study Group. Initial results from a prospective cohortstudy of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 2000; 89:202-217.
23. Van den Bruel A, Moreno-Reyes R, Bex M, et al. Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines? Results of a national survey. Clin Endocrinol 2008; 68:599-604. (Pubitemid 351388714)
24. Kouvaraki MA, Greer M, Sharma S, et al. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery 2006; 139:527-534.
25. Famakinwa OM, Roman SA, Wang TS, Sosa JA. ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg 2010; 199:189-198.